Amundi’s AngioDynamics ANGO Stock Holding History

Amundi’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,261	Closed	-$54.3K	–	2007
2023 Q2	$54.3K	Sell	5,261 -61	-1%	-$587	﹤0.01%	1882
2023 Q1	$50.7K	Buy	+5,322	New	+$68.1K	﹤0.01%	1883

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi's ANGO Position: Q3 2023 in Review

Amundi sold out of AngioDynamics (ANGO) in Q3 2023, closing a stake of 5,261 shares — an estimated $54.3K sold.

Amundi first reported a position in ANGO in Q1 2023 and held it in 2 quarters. The position peaked at $54.3K in Q2 2023. 154 funds tracked by Wall St. Rank hold ANGO as of Q3 2023.

Amundi reported no remaining AngioDynamics position as of Q3 2023 after selling out during the quarter.
Amundi sold 5,261 AngioDynamics shares in Q3 2023, an estimated $54.3K.
Amundi first reported a position in AngioDynamics in Q1 2023 and held it in 2 quarters.
Amundi's AngioDynamics position peaked at $54.3K in Q2 2023.
154 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2023.

Based on Amundi's 13F filing for Q3 2023, filed 14 Nov 2023.